BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18598106)

  • 1. Molecular profiling in the age of cancer genomics.
    Lin J; Li M
    Expert Rev Mol Diagn; 2008 May; 8(3):263-76. PubMed ID: 18598106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and proteomics: emerging technologies in clinical cancer research.
    Chung CH; Levy S; Chaurand P; Carbone DP
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer: a proteomic disease.
    Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
    Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of expression genomics for predicting treatment response in cancer.
    Chin KV; Alabanza L; Fujii K; Kudoh K; Kita T; Kikuchi Y; Selvanayagam ZE; Wong YF; Lin Y; Shih WC
    Ann N Y Acad Sci; 2005 Nov; 1058():186-95. PubMed ID: 16394136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational prediction of cancer-gene function.
    Hu P; Bader G; Wigle DA; Emili A
    Nat Rev Cancer; 2007 Jan; 7(1):23-34. PubMed ID: 17167517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing takes centre stage in cancer profiling.
    Maher B
    Nature; 2009 May; 459(7244):146-7. PubMed ID: 19444175
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
    Mitra AP; Lin H; Cote RJ; Datar RH
    Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of human cancer: new opportunities.
    Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
    Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oncoproteomics in the personalized management of cancer.
    Jain KK
    Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of expression profiling and proteomics in prostate cancer.
    Masters JR
    Anticancer Res; 2007; 27(3A):1273-6. PubMed ID: 17593619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy.
    Meyerson M; Carbone D
    J Clin Oncol; 2005 May; 23(14):3219-26. PubMed ID: 15886309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies for therapeutic design in molecular oncology using gene expression profiles.
    Ricci MS; el-Deiry WS
    Curr Opin Mol Ther; 2000 Dec; 2(6):682-90. PubMed ID: 11249746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic approaches in cancer risk and response assessment.
    Petricoin EF; Liotta LA
    Trends Mol Med; 2004 Feb; 10(2):59-64. PubMed ID: 15102358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA microarrays: identification of gene signatures and their application in clinical practice.
    Magic Z; Radulovic S; Brankovic-Magic M
    J BUON; 2007 Sep; 12 Suppl 1():S39-44. PubMed ID: 17935276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer genomics: promises and complexities.
    Zhang W; Labordé PM; Coombes KR; Berry DA; Hamilton SR
    Clin Cancer Res; 2001 Aug; 7(8):2159-67. PubMed ID: 11489789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primer: genomic and proteomic tools for the molecular dissection of disease.
    Walker EJ; Siminovitch KA
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):580-9. PubMed ID: 17906613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systems approach to model metastatic progression.
    Taylor BS; Varambally S; Chinnaiyan AM
    Cancer Res; 2006 Jun; 66(11):5537-9. PubMed ID: 16740685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.